Haas Kevin Richard 4

What Happened Kevin Richard Haas, formerly Chief Technology Officer of Myriad Genetics (MYGN), had a total of 22,310 shares disposed via issuer withholding to satisfy tax obligations tied to the vesting of restricted stock units (RSUs) and performance-based RSUs. The withholding occurred across transactions March 13–15, 2026 at a price of $4.66 per share, resulting in cash values of $29,880, $19,390, $15,634 and $39,060 (total ≈ $103,964). These were not open-market sales but share retentions by the company to cover taxes.

Key Details

• Transaction dates & amounts:
  • 2026-03-13: 6,412 shares withheld — $29,880
  • 2026-03-14: 4,161 shares withheld — $19,390
  • 2026-03-15: 3,355 shares withheld — $15,634
  • 2026-03-15: 8,382 shares withheld — $39,060
• Withholding price: $4.66 per share (based on Myriad's March 13, 2026 closing price).
• Total shares withheld: 22,310; total value ≈ $103,964.
• Shares owned after the transactions: not disclosed in the provided filing.
• Footnotes: Company withheld shares to satisfy tax withholding on vested RSUs and performance-based RSUs; amounts were determined using the March 13 closing price.
• Filing/timeliness: Report covering 3/13–3/15 transactions was filed 2026-03-16; filing is not flagged as late.
• Additional remark from filing: Haas is no longer serving as CTO effective March 16, 2026 and is no longer subject to Section 16 reporting.

Context These transactions are routine tax-withholding actions tied to equity vesting (not open-market sales or purchases). For retail investors, tax-withholdings typically do not signal insider sentiment about the company’s prospects; they simply settle tax obligations when RSUs vest.